학술논문
Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study
Document Type
Article
Author
Asokan, M.S.; Babji, S.; Immanuel, S.; Kang, G.; Nadukkandy, P.; Subrahmanyam, V.; Pandey, A.; Saha, S.; Shivaraj, A.; Panikulam, P.; Shome, R.; Gulzar, S.-E.-J.; Sundaramurthy, V.; John, J.; Raghu, P.; Mayor, S.; Joan, R.F.; Rajukutty, S.; Inbaraj, L.R.; Chandrasingh, S.; George, C.E.; Dayma, G.; Agarwal, D.; Kawade, A.; Malagi, G.; Arya, P.; Mahajan, V.; Chaturvedi, A.; Bhavikatti, J.; Pawar, K.; Thorat, A.; Naik, A.; Talashi, S.; Belekar, M.; Yadav, R.; Raghunathan, A.; Shah, P.; Khude, P.; Shashidhara, L.S.; Goud, R.B.; V, M.; Shivalingaiah, S.; Johnson, A.; Ramesh, N.; Chetan, N.; Parthiban, C.; Ahmed, A.; Rakshit, S.; Adiga, V.; D'souza, G.; Dias, M.; Vyakarnam, A.; Roy, B.; Deshmukh, U.; Bhise, C.; Joshi, M.; Rale, V.; Bhosale, A.; Sharma, A.U.; Jamora, C.; Karumbati, A.S.; Ghose, A.; Bal, V.
Source
In: The Lancet Regional Health - Southeast Asia . (The Lancet Regional Health - Southeast Asia, March 2024, 22)
Subject
Language
English
ISSN
27723682